DMK Pharmaceuticals Corp Watch

from DEFA14A 100 pages Agreement and Plan of Merger and Reorganization Between Adamis Pharmaceuticals Corporation, a Delaware Corporation, Aardvark Merger Sub, Inc., a Delaware Corporation and Dmk Pharmaceuticals Corporation, a New Jersey Corporation Dated as of February 24, 2023

from 8-K 100 pages Agreement and Plan of Merger and Reorganization Between Adamis Pharmaceuticals Corporation, a Delaware Corporation, Aardvark Merger Sub, Inc., a Delaware Corporation and Dmk Pharmaceuticals Corporation, a New Jersey Corporation Dated as of February 24, 2023

from 8-K 12 pages Asset Purchase Agreement

from 8-K 12 pages Joinder Agreement and General Release

from 8-K 110 pages Agreement and Plan of Merger Dated as of March 28, 2016 by and Among Adamis Pharmaceuticals Corporation, as Apc US Compounding, Inc., as the Company Ursula Mergersub Corp., as Merger Sub and Eddie Glover, as the Stockholders’ Representative

from SC 13D/A 3 pages Third Amendment to Common Stock Purchase Agreement

from SC 13D/A 3 pages Second Amendment to Common Stock Purchase Agreement

from 425 ~50 pages Agreement and Plan of Reorganization Among La Jolla Pharmaceutical Company a Delaware Corporation, Jewel Merger Sub, Inc., a Delaware Corporation and Adamis Pharmaceuticals Corporation, a Delaware Corporation Dated as of December 4, 2009

from 8-K 2 pages [Signature Page to Follow]

from 425 2 pages [Signature Page to Follow]

from S-4 13 pages Voting Agreement

from 8-K ~1 page “(B) by Either Cellegy or Adamis if the Merger Shall Not Have Been Consummated by December 31, 2008 (The “Outside Date”); Provided, However, That the Right to Terminate This Agreement Under This Section 9.1(b) Shall Not Be Available to Any Party Whose Failure to Fulfill or Diligently Pursue Fulfillment of Any Material Obligation Under This Agreement Has Been a Principal Cause of or Resulted in the Failure of the Merger to Occur on or Before the Outside Date;” Other Than Expressly Set Forth in This Letter Agreement, the Agreement Shall Be Unmodified and in Full Force and Effect. Please Confirm Your Agreement by Signing a Copy of This Letter Below. Very Truly Yours, Cellegy Pharmaceuticals, Inc. By: S/ Richard C. Williams Richard C. Williams, CEO Agreed and Acknowledged: Adamis Pharmaceuticals Corporation By: S/ Dennis J. Carlo Dennis J. Carlo, President/CEO

from 425 13 pages Voting Agreement

from 8-K 13 pages Voting Agreement

from 425 67 pages Agreement and Plan of Reorganization Between Cellegy Pharmaceuticals, Inc., a Delaware Corporation, Cellegy Holdings, Inc. a Delaware Corporation and Adamis Pharmaceuticals Corporation, a Delaware Corporation Dated as of February 12, 2008

from 8-K 67 pages Agreement and Plan of Reorganization Between Cellegy Pharmaceuticals, Inc., a Delaware Corporation, Cellegy Holdings, Inc. a Delaware Corporation and Adamis Pharmaceuticals Corporation, a Delaware Corporation Dated as of February 12, 2008

from 10-Q 13 pages Background

from 10-Q/A 13 pages Background

from 8-K 65 pages Agreement and Plan of Share Exchange Between Cellegy Pharmaceuticals, Inc. and Biosyn, Inc. a Pennsylvania Corporation Dated as of October 7, 2004

from 8-K 5 pages Agreement and Plan of Merger and Reincorporation